关于 "Reverse Transcriptase" 的结果12 个结果
筛选:Signaling Pathways×
- Tenofovir diphosphate (sodium salt)
An HIV reverse transcriptase and HBV polymerase inhibitor
- 2',3'-Dideoxyadenosine 5'-triphosphate (lithium salt)
An inhibitor of reverse transcriptases and DNA polymerases
- TirucallolCAS: 514-46-5
A triterpenoid with reverse transcriptase inhibitory and anti-inflammatory activities
- Aminopeptidase N InhibitorCAS: 596108-59-7
Aminopeptidase N (AP-N) inhibitor is a reversible inhibitor of AP-N/CD13 (IC50 = 25 μM).
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC45012 | Tenofovir diphosphate (sodium salt) | - | Drug Metabolite | ||
An HIV reverse transcriptase and HBV polymerase inhibitor | |||||
| GC52501 | 2',3'-Dideoxyadenosine 5'-triphosphate (lithium salt) | - | HIV | ||
An inhibitor of reverse transcriptases and DNA polymerases | |||||
| GC63228 | Tirucallol | 514-46-5 | Others | ||
A triterpenoid with reverse transcriptase inhibitory and anti-inflammatory activities | |||||
| GC41251 | Pirlindole | 60762-57-4 | Viral Diseases | ||
A selective and reversible MAO-A inhibitor | |||||
| GC67613 | Sugammadex | 343306-71-8 | Others | ||
A steroid-based neuromuscular blocker reversing agent | |||||
| GC42667 | Abacavir Carboxylate | 384380-52-3 | Drug Metabolite | ||
An inactive metabolite of abacavir | |||||
| GC42788 | Aminopeptidase N Inhibitor | 596108-59-7 | Proteolysis | ||
Aminopeptidase N (AP-N) inhibitor is a reversible inhibitor of AP-N/CD13 (IC50 = 25 μM). | |||||
| GC25581 | LM11A-31 | 289475-77-0 | Others | ||
LM11A-31 is a small molecule p75NTR Ligand that reverses cholinergic neurite dystrophy in alzheimer's diseasemousemodels with mid- to late-stage disease progression | |||||
| GC63794 | ARN19702 | 1971937-18-4 | Others | ||
ARN19702 is an orally active, reversible N-Acylethanolamine acid amidase(NAAA) inhibitor (IC50 on human NAAA = 230 nM) that produces remarkable protective effects against multiple sclerosis in mice. | |||||
| GC63192 | Simufilam | 1224591-33-6 | Others | ||
Simufilam(PTI-125) is potent, orally active small drug against AD, which interacts to filamin and controls the actin cytoskeleton. Simufilam reduces tau hyperphosphorylation, amyloid and tau formation by preventing and reversing the binding of Aβ42 to α7nAChR. | |||||
| GC42919 | Benzonatate | 104-31-4 | Neuroscience | ||
A voltage-gated sodium channel blocker | |||||
| GC43806 | HC Toxin | 83209-65-8 | Histone Deacetylation | ||
Potent HDAC inhibitor | |||||